
Formulary Search
You are here : Home > Formulary Search
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Search Results : Congenital adrenal hyperplasia (Hydrocortisone - Congenital adrenal hyperplasia)
Records returned : 13 (on 29 May 2025 at 13:18:50).
Return to search results for ' Congenital adrenal hyperplasia '.
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
Cancer Drugs Fund
ICB
Treatment commissioned by the ICB
Link to the NICE website

Low carbon device
Status Key
Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
See narrative
See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Blue
Formulations :
- Granules in capsules for opening
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For infants / children on doses BELOW 5mg. Capsules for opening. 0.5mg, 1mg and 2mg only.
Doses of 5mg or more - to halve a 10mg tablet and use lower strength capsules to achieve correct dose. Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
SPC
R
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
See PAD for guidance on providing reserve supplies for dosing during acute illness
10mg tablets can be halved for doses of 5mg. Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For patients on dose of 10mg AND unable to swallow solid dose forms.
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Links :
SPC
R
Indication :
Status :
Blue
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
2nd line option. Primary Care may initiate prescribing on request from the specialist endocrinology team.
Links :
Indication :
Status :
Red
Formulations :
- Oral solution
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For use in infants and children where smaller doses are required.
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Buccal tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
(MHRA drug safety update December 2018) https://www.gov.uk/drug-safety-update/hydrocortisone-muco-adhesive-buccal-tablets-should-not-be-used-off-label-for-adrenal-insufficiency-in-children-due-to-serious-risks
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
2nd line option. Requests for primary care prescribing on recommendation from specialist endocrinology team only.
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Oral solution
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
Reserved for patients who are unable to swallow solid dose forms. Requests for primary care prescribing by the specialist endocrinology teams only.
Formulary Status :
Links :
SPC
R
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
For advice on dosing of glucocorticoids during acute illness please see PAD page
2nd line option. Requests for primary care prescribing on recommendation from specialist endocrinology team only.
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
For patients unable to swallow solid dose forms.
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
SPC
R
Indication :
Status :
Blue
Formulations :
- Oral solution
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
For use in patients who are unable to swallow solid dose forms. Request for primary care prescribing after initiation and stabilisation - at least 1 month supply from specialist team.
Formulary Status :
Links :
SPC
R
Indication :
Status :
Non Formulary
Formulations :
- Enteric coated tablets
Restrictions / Comments:
Important
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate.
- See PAD for guidance on providing reserve supplies for dosing during acute illness
Formulary Status :
Links :